SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-169187
Filing Date
2023-06-20
Accepted
2023-06-16 18:54:29
Documents
13
Period of Report
2023-06-15
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d521638d8k.htm   iXBRL 8-K 40061
2 EX-3.1 d521638dex31.htm EX-3.1 5155
  Complete submission text file 0001193125-23-169187.txt   177971

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20230615.xsd EX-101.SCH 2871
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20230615_lab.xml EX-101.LAB 19502
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20230615_pre.xml EX-101.PRE 12170
7 EXTRACTED XBRL INSTANCE DOCUMENT d521638d8k_htm.xml XML 3710
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 231022804
SIC: 2834 Pharmaceutical Preparations